Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CLOVER HEALTH INVESTMENTS, CORP. /DECLOV · Entity 4419 | Chief Financial Officer | January 29, 2026 | February 02, 2026 |
| INVACARE HOLDINGS CorpIVCRQ · Entity 86444 | Director | November 01, 2023 | November 03, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CLOVER HEALTH INVESTMENTS, CORP. /DE
Report date January 29, 2026 · Filed February 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 5,758,353 |
Reported balance
After 2026-01-29 transaction · row 1
1 source rowRow 1 · 2026-01-29 · Tax withholding · Disposed 156,856 · Balance 5,758,353 F1: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on January 29, 2026, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on April 29, 2024. The remaining RSUs vest in equal quarterly installments, with a final vesting date on April 29, 2028, in each case subject to the continued service of the Reporting Person on such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on January 29, 2026, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on April 29, 2024. The remaining RSUs vest in equal quarterly installments, with a final vesting date on April 29, 2028, in each case subject to the continued service of the Reporting Person on such vesting date.
INVACARE HOLDINGS Corp
Report date November 01, 2023 · Filed November 03, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 66,860 |
Reported balance
After 2023-11-01 transaction · row 1
1 source rowRow 1 · 2023-11-01 · Grant · Acquired 66,860 · Balance 66,860 F1: The restricted stock units vest in one installment on May 5, 2024, subject to the reporting person's continued service on the board of directors. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units vest in one installment on May 5, 2024, subject to the reporting person's continued service on the board of directors.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
OMNICELL, INC.
Report date June 15, 2023 · Filed June 16, 2023
Section 16 reporting ended · disclosed 2023-06-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 54,900 |
Reported balance
After 2023-06-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-06-15 · Tax withholding · Disposed 2,292 · Balance 54,900 F1: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. F2: The balance is adjusted to reflect 62 shares purchased under the Issuer's Employee Stock Purchase Plan on 2/15/23. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.
F2: The balance is adjusted to reflect 62 shares purchased under the Issuer's Employee Stock Purchase Plan on 2/15/23.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 09, 2017 Filed Aug 9, 2017 23:43 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 8,000 | $50.24 | $401,890.40 |
DisclosureSEC source: 0001179110-17-011311 · edgar.xml · nonDerivative · entry 4 Kuipers Peter J. · CIK 0001651691 · Executive V.P. CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,246 F3 · price: The price reported in Column 4 is the average price of $50.2363. The shares sold between $50.10 to $50.60. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 09, 2017 Filed Aug 9, 2017 23:43 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 14,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-011311 · edgar.xml · nonDerivative · entry 3 Kuipers Peter J. · CIK 0001651691 · Executive V.P. CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,246 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2017 Filed Aug 9, 2017 23:43 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 3,522 | $50.51 | $177,882.13 |
DisclosureSEC source: 0001179110-17-011311 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V.P. CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,714 F1 · shares: The price reported in Column 4 is the average price of $50.5060. The shares sold between $50.22 to $50.60. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 15, 2017 Filed Jun 16, 2017 21:38 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 1,353 | $42.95 | $58,111.35 |
DisclosureSEC source: 0001179110-17-009220 · edgar.xml · nonDerivative · entry 3 Kuipers Peter J. · CIK 0001651691 · Executive V.P. CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,236 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 15, 2017 Filed Jun 16, 2017 21:38 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 339 | $42.95 | $14,560.05 |
DisclosureSEC source: 0001179110-17-009220 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V.P. CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,589 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| March 07, 2017 Filed Mar 9, 2017 22:14 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 761 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-004340 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V.P. CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,928 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| February 08, 2017 Filed Feb 11, 2017 00:24 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantStock Option (Right to Buy) · Derivative | 34,390 | $0.00 Strike: $36.70 | $0.00 |
DisclosureSEC source: 0001179110-17-002188 · edgar.xml · derivative · entry 4 Kuipers Peter J. · CIK 0001651691 · Executive V.P. CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,390 Underlying: Common Stock · 34,390 shares Expires 2027-02-08 F2 · shares: Shares shall vest ratably over 48 month period, with a year cliff. Read SEC document |
| February 08, 2017 Filed Feb 11, 2017 00:24 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 13,960 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-002188 · edgar.xml · nonDerivative · entry 3 Kuipers Peter J. · CIK 0001651691 · Executive V.P. CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,689 F3 · shares: The Performance-based restricted stock unit awards vest as to 25% of the shares on the date of the Compensation Committee meeting in 2018 when the Committee reviews the performance-based metrics and determines if they were met or not with the remaining shares vesting on a semi-annual basis over a period of thirty-six months commencing on June 15, 2018 if the Company meets certain stock performance objectives compared to the NASDAQ Healthcare Index. The actual number of performance based stock awards that vest may be 0%, 50% or 100% of the numbers reflected above, depending upon the Company's performance. Read SEC document |
| February 08, 2017 Filed Feb 11, 2017 00:24 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 4,190 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-002188 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V.P. CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,729 F1 · shares: Restricted Stock Units shall vest semiannually on 6/15 and 12/15 for a period of 4 years. Read SEC document |
| December 15, 2016 Filed Dec 16, 2016 22:43 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 1,157 | $33.90 | $39,222.30 |
DisclosureSEC source: 0001179110-16-033150 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V.P. CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,539 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.